<DOC>
	<DOCNO>NCT00763698</DOCNO>
	<brief_summary>This prospective , multi-center non-randomized clinical study evaluate safety efficacy QuickFlex Micro Model 1258T leave ventricular lead heart failure patient population . The study conduct maximum 20 investigational center locate United States total 68 patient enrol .</brief_summary>
	<brief_title>Safety Efficacy Study QuickFlex Micro Model 1258T Left Heart Pacing Lead</brief_title>
	<detailed_description>The investigational left heart lead , QuickFlex Model 1258T , implant legally marketed St. Jude Medical cardiac resynchronization therapy implantable cardioverter defibrillator ( CRT-D ) device . Patients follow Pre-Discharge , 1-Month , 3-Month , every 6 month end study .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Approved indication CRTD system Previous cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within 3 month enrollment Previous leave ventricular ( LV ) lead implant Have heart attack , unstable angina cardiac revascularization ( percutaneous transluminal coronary angioplasty ( PTCA ) , coronary artery bypass grafting ( CABG ) , Stent ) within 40 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Left heart pace lead</keyword>
	<keyword>Cardiac resynchronization therapy ( CRT )</keyword>
	<keyword>Heart failure</keyword>
	<keyword>ICD</keyword>
</DOC>